See All Slides - tctmd.com

Slides

Presentation TCT 2012

DES the Year in Review: Trends, Utilization, Science, and Controversies

Presenter: Martin Leon

October 22, 2012

Presentation TCT 2012

The VARC 2 Consensus Document: Meaningful Refinements to Improve TAVR Clinical Research

Presenter: Stuart Head

October 22, 2012

Presentation TCT 2012

Non-Left Main Bifurcation Stenting: Updated Meta-analysis of Simple vs. Complex Techniques

Presenter: Somjot Brar

October 22, 2012

Presentation TCT 2012

The “Heart Team” Management Approach in Valvular Heart Disease: Components and Value Proposition - A Sustainable Model for the Future?

Presenter: A. Pieter Kappetein

October 22, 2012

Presentation TCT 2012

SDF-1: Circumventing the Application of Cell Products in Heart Failure

Presenter: Warren Sherman

October 22, 2012

Presentation TCT 2012

Tips and Tricks in LAA Deployment

Presenter: William Gray

October 22, 2012

Presentation TCT 2012

Retrograde Coronary Injection: Current and Evolving Status

Presenter: Amit Patel

October 22, 2012

Presentation TCT 2012

RESOLUTE All-Comers at Three Years

Presenter: Sigmund Silber

October 22, 2012

Presentation TCT 2012

Fiberoptic Cardioscopy for Use in Epicardial Injection of Cell Suspensions and Biomaterials

Presenter: Henricus Duckers

October 22, 2012

Presentation TCT 2012

The Importance of Frailty Assessments in TAVR Patient Selection: Phenotype Description, Measurement Tools, and Impact on Clinical Outcomes

Presenter: Philip Green

October 22, 2012

Advertisement

Slides

DES the Year in Review: Trends, Utilization, Science, and Controversies

The VARC 2 Consensus Document: Meaningful Refinements to Improve TAVR Clinical Research

Non-Left Main Bifurcation Stenting: Updated Meta-analysis of Simple vs. Complex Techniques

The “Heart Team” Management Approach in Valvular Heart Disease: Components and Value Proposition - A Sustainable Model for the Future?

SDF-1: Circumventing the Application of Cell Products in Heart Failure

Tips and Tricks in LAA Deployment

Retrograde Coronary Injection: Current and Evolving Status

RESOLUTE All-Comers at Three Years

Fiberoptic Cardioscopy for Use in Epicardial Injection of Cell Suspensions and Biomaterials

The Importance of Frailty Assessments in TAVR Patient Selection: Phenotype Description, Measurement Tools, and Impact on Clinical Outcomes

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content